The prevalence of dyslipidemia (including in TC, TG, LDL-C and apoB) increased with increasing OSA severity in non-obese subjects and those <55 years of age not in obese or older subjects (except apoA-I in older subjects) (Supplementary Table S2). This evidence concerns the gene APOB and metabolic syndrome.